Extracorporeal Photopheresis as Treatment Option of Chronic Lung Allograft Dysfunction. Is ECP the Therapy of the Future?

被引：0
|
作者：
Benazzo, A. [1 ]
Landl, M. [1 ]
Mockenhuber, M. [1 ]
Schwarz, S. [1 ]
Murakoezy, G. O. [1 ]
Lambers, C. O. [1 ]
Moser, B. [1 ]
Hoetzenecker, K. [1 ]
Siguenza, J. O. Matilla [1 ]
Lang, G. O. [1 ]
Taghavi, S. [1 ]
Klepetko, W. [1 ]
Jaksch, P. [1 ]
机构：
[1] Med Univ Vienna, Thorac Surg, Vienna, Austria
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.healun.2018.01.263
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
260
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [41] Safety and feasibility of extracorporeal photopheresis (ECP) as second-line therapy for treatment of pediatric patients with acute GvHD
    Luther, Marlene
    Olfe, Lisa
    Movassaghi, Kamran
    Lange, Ina
    Kuenkele, Annette
    Schulte, Johannes
    Eggert, Angelika
    Blum, Agnieszka
    Uharek, Lutz
    Tietze-Buerger, Carola
    BONE MARROW TRANSPLANTATION, 2018, 53 : 238 - 239
  • [42] Everolimus Treatment for Chronic Lung Allograft Dysfunction in Lung Transplantation
    Iturbe-Fernandez, David
    Gafas, Alicia de Pablo
    Cuesta, Victor Manuel Mora
    Moralejo, Rodrigo Alonso
    Loaiza, Carlos Andres Quezada
    Perez Gonzalez, Virginia
    Lopez-Padilla, Daniel
    Cifrian, Jose M.
    LIFE-BASEL, 2024, 14 (05):
  • [43] The use of extracorporeal photopheresis in the treatment of acute cardiac allograft rejection
    Teszak, T. Timea
    Assabiny, A.
    Kiraly, A.
    Tarjanyi, Z.
    Parazs, N.
    Szakal-Toth, Z. S.
    Hartyanszky, I.
    Szabolcs, Z.
    Farkas, Z.
    Reti, M.
    Sax, B.
    Merkely, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 84 - 84
  • [44] Epithelial-mesenchymal transition in chronic lung allograft dysfunction. Role of leucocyte microparticles
    Renaud-Picard, Benjamin
    Toussaint, Justine
    El Ghazouani, Fatiha
    Toti, Florence
    Kessler, Laurence
    Kessler, Romain
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [45] Changing the curve in chronic lung allograft dysfunction: Implications of chronic lung allograft dysfunction phenotypes in assessing treatment interventions
    Mooney, Joshua J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (03): : 319 - 320
  • [46] Increased lipoproteins and fibrinogen in chronic renal allograft dysfunction.
    Fernández-Miranda, C
    de Bustillo, EM
    Morales, JM
    Porres, A
    Gomez-Gerique, J
    Guijarro, C
    Aranda, JL
    Andrés, A
    Rodicio, JL
    Del Palacio, A
    KIDNEY INTERNATIONAL, 1999, 55 (01) : 374 - 374
  • [47] Extracorporeal photopheresis as cell therapy for lung transplant rejection
    Del Fante, C.
    Perotti, C.
    Viarengo, G.
    Cascina, A.
    Oggionni, T.
    Scudeller, L.
    Meloni, F.
    Salvaneschi, L.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S318 - S318
  • [48] USE OF ALEMTUZUMAB IN THE TREATMENT OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION
    Thachuthara-George, Joseph
    Crow, Stacy A.
    Hood, Cheryl L.
    Bridges, Sydney A.
    Derksen, Thomas
    Sinha, Neeraj
    Soma, Jyothula
    Mankidy, Babith
    Kaleekal, Thomas
    Seethamraju, Harish
    Brukner, Brian
    Loebe, Mathias
    Scheinin, Scott
    TRANSPLANT INTERNATIONAL, 2015, 28 : 701 - 701
  • [49] EXTRACORPOREAL PHOTOPHERESIS (ECP) AS A TREATMENT OF GRAFTED AND CURRENT HUSBAND'S DISEASE: EXPERIENCE OF A CENTER
    Carrillo Checa, J.
    Lopez Parra, M.
    Lopez Villar, O.
    Avendano Pita, A.
    Rivera Delgado, D.
    Presa Morales, D.
    Higuero Saavedra, V
    Sobejano Fuertes, E.
    Martin Lopez, A. A.
    Perez Lopez, E.
    Cabrero Calvo, M.
    Vazquez Lopez, L.
    Sanchez Guijo, F.
    Caballero Barrigon, Ma D.
    Lopez Corral, L.
    HAEMATOLOGICA, 2018, 103 : 250 - 251
  • [50] Efficacy of extracorporeal photopheresis (ECP) monotherapy in the treatment of cutaneous T cell lymphoma (CTCL)
    Knobler, R.
    Foss, F.
    Duvic, M.
    Straus, D.
    Horwitz, S.
    Zain, J.
    Kuzel, T.
    Querfeld, C.
    Campbell, K.
    Geskin, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S201 - S201
12345